• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-04

  This product provides HRP-based detection of rabbit IgG primary antibodies in Western blotting, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only, with assay-specific dilution and substrate conditions requiring local validation; it should not be used for diagnostic, medical, or non-rabbit primary-antibody applications without appropriate validation.

• RITA (NSC 652287): Applied Research Workflows

  2026-09-03

  RITA (NSC 652287) combines MDM2–p53 pathway interrogation with DNA cross-link biology, making it useful for mechanism-focused cancer biology and renal carcinoma research. This guide shows how to separate growth inhibition from true cell killing, optimize dosing and apoptosis assay design, and interpret in vitro findings alongside tumor xenograft evidence.

• Aconitase Assay in CD8+ T Cell Metabolism

  2026-09-02

  Learn how the Aconitase Activity Colorimetric Assay Kit can complement CD8+ T-cell immunometabolism studies without confusing aconitase activity with glycolytic or splicing endpoints. This guide connects iron-sulfur enzyme chemistry, oxidative damage measurement, and practical experimental design.

• AZD6482: PI3Kβ Inhibitor Workflow

  2026-09-02

  AZD6482 enables isoform-resolved PI3Kβ studies across kinase signaling, adipocyte glucose uptake, and platelet biology. This workflow also explains how to use the compound cautiously in hypothesis-generating DM1 RNA-foci experiments without confusing an exploratory extension with evidence from the reference study.

• Busulfan and the Limits of Ovarian Regeneration

  2026-09-02

  Busulfan is more than an ovarian injury reagent: it is a mechanistically defined DNA alkylating agent that can expose the difference between tissue damage, cellular depletion, and true lineage replacement. New dual-recombinase tracing strengthens the case that busulfan-injured mouse ovaries do not regenerate oocytes in vivo.

• IWP-2 Workflow for Wnt Production Inhibition

  2026-09-01

  IWP-2 provides an upstream way to suppress Porcupine-dependent Wnt secretion, helping researchers connect pathway blockade with proliferation, invasion, apoptosis, and cell morphology. This practical guide combines product handling, a gastric cancer workflow, and high-content profiling principles inspired by a cardiomyopathy study.

• Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies

  2026-08-31

  Jorge and colleagues show that parthenolide reduces metabolic activity and promotes oxidative-stress-associated apoptosis across diverse lymphoid malignancy models, while the detailed mechanism varies by cell line. The study is valuable because it combines a resazurin-based cell viability assay with flow-cytometric and transcriptional measurements to connect reduced metabolic activity with ROS accumulation, glutathione loss, mitochondrial depolarization, and apoptotic signaling.

• Betaine Hydrochloride in Inflammation Assays

  2026-08-31

  Explore how Betaine hydrochloride can support controlled metabolic enzyme, protease, cell culture, and molecular biology workflows without being confused with an anti-inflammatory treatment. This article translates a recent esophageal cancer study into practical assay-design decisions, controls, and limitations.

• Regorafenib, RRM2, and Melanoma Progression

  2026-08-30

  The 2024 iScience study identifies RRM2 as a mechanistically important downstream effector of regorafenib in melanoma. By combining phenotypic assays, RNA sequencing, perturbation and rescue experiments, and xenograft validation, the work connects multikinase inhibition with ERK/E2F3-associated control of melanoma growth, invasion, and apoptosis.

• Polybrene for Viral Delivery and p53 Assays

  2026-08-29

  Polybrene (Hexadimethrine Bromide) improves viral attachment and uptake while supporting difficult lipid-mediated DNA transfection workflows. This practical guide shows how to use it as a delivery aid for mutant-p53 assay development without confusing transduction enhancement with direct p53 reactivation.

• Diminazene Aceturate: Research Workflows

  2026-08-28

  Diminazene Aceturate supports two distinct research tracks: trypanocidal screening in parasite models and pathway-oriented ACE2 activation research. This guide translates its formulation data and recent cardiac-injury findings into practical workflows, controls, and troubleshooting strategies.

• 25-Hydroxycholesterol, AMPK, and TAM Reprogramming

  2026-08-28

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that connects lysosomal cholesterol handling with AMPKα–STAT6 signaling in tumor-associated macrophages. Their findings explain how macrophages acquire immunosuppressive properties and suggest that CH25H targeting may improve T-cell surveillance and anti-PD-1 responses.

• Direct Mouse Genotyping Kit: PCR Workflow

  2026-08-28

  The Direct Mouse Genotyping Kit supports rapid genomic DNA release and PCR amplification directly from mouse tissue lysates, avoiding conventional DNA purification for routine mouse genetic screening. It is intended for PCR-based genotyping and high-throughput workflows, not for applications requiring ultra-pure DNA or downstream enzymatic assays beyond PCR.

• A-1155463: Mapping BCL-XL Apoptotic Dependence

  2026-08-27

  The BCL-XL inhibitor A-1155463 offers a precise way to test mitochondrial apoptosis dependence in resistant cancer models. This article translates glioblastoma findings into experimentally useful decisions about cell state, apoptotic priming, assay endpoints, and preclinical interpretation.

• GSK J4 HCl: JMJD3 Inhibitor Workflows

  2026-08-26

  GSK J4 HCl converts JMJD3 biology into practical assays for chromatin, inflammation, and cancer research. Its intracellular conversion to GSK J1 supports cell-based experiments that connect H3K27 demethylation with cytokine output, promoter occupancy, and tumor-model phenotypes.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page